| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/HEAD.13018 |
| P698 | PubMed publication ID | 28127754 |
| P2093 | author name string | James L Bernat | |
| Nathaniel M Robbins | |||
| P2860 | cites work | Association of trypanolytic ApoL1 variants with kidney disease in African Americans | Q24606581 |
| Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine | Q24611845 | ||
| Are racial and ethnic minorities less willing to participate in health research? | Q24814743 | ||
| Characterizing Race/Ethnicity and Genetic Ancestry for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort | Q26810487 | ||
| Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual... | Q27023862 | ||
| Self-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparities | Q28651487 | ||
| Biological races in humans | Q28686449 | ||
| Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy | Q30399701 | ||
| Lower use of carotid artery imaging at minority-serving hospitals | Q30519509 | ||
| Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement. | Q30780552 | ||
| The inclusion of minority groups in clinical trials: problems of under representation and under reporting of data. | Q30986560 | ||
| Prevalence and burden of migraine in the United States: data from the American Migraine Study II. | Q31974113 | ||
| Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review | Q33300205 | ||
| Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study | Q34033827 | ||
| Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial | Q34035463 | ||
| BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study | Q34155864 | ||
| Intranasal ketorolac tromethamine (SPRIX(R)) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: safety and efficacy data from a phase II clinical trial | Q34308609 | ||
| Historical background of clinical trials involving women and minorities | Q34333021 | ||
| Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks | Q34365432 | ||
| BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial | Q34365650 | ||
| Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study | Q34393819 | ||
| Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis | Q34432986 | ||
| Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial | Q34442510 | ||
| A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study). | Q35061116 | ||
| Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls | Q35609281 | ||
| Diversity of participants in clinical trials in an academic medical center: the role of the 'Good Study Patient?'. | Q40012032 | ||
| Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. | Q40472458 | ||
| The inclusion of women in clinical trials of antihypertensive medications: a review of twenty-four trials in one pharmacology journal | Q40544063 | ||
| Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study | Q41693303 | ||
| Efficacy and tolerability of subcutaneous sumatriptan for acute migraine: a comparison between ethnic groups | Q43795861 | ||
| Migraine prevalence, disease burden, and the need for preventive therapy | Q43983035 | ||
| Race and income disparity in ischemic stroke care: nationwide inpatient sample database, 2002 to 2008. | Q44043421 | ||
| Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention | Q44851293 | ||
| Distinguishing language and race disparities in epilepsy surgery | Q44935624 | ||
| Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine | Q45018129 | ||
| Race/ethnicity, quality of care, and outcomes in ischemic stroke | Q45354954 | ||
| Recent racial/ethnic disparities in stroke hospitalizations and outcomes for young adults in Florida, 2001-2006. | Q46087876 | ||
| Explaining racial and ethnic disparities in health care | Q46166317 | ||
| Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study | Q47644533 | ||
| Randomized controlled study of telcagepant plus ibuprofen or acetaminophen in migraine | Q50265031 | ||
| Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial. | Q50758391 | ||
| Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. | Q51229352 | ||
| Frovatriptan as preemptive treatment for fasting-induced migraine. | Q51380995 | ||
| Migraine prevalence by age and sex in the United States: a life-span study. | Q51547125 | ||
| Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. | Q51703728 | ||
| Reporting of race and ethnicity in breast cancer research: room for improvement. | Q51830154 | ||
| Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial. | Q52856000 | ||
| Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis. | Q53120499 | ||
| Topiramate intervention to prevent transformation of episodic migraine: The topiramate INTREPID study | Q53453551 | ||
| Race, Medical Researcher Distrust, Perceived Harm, and Willingness to Participate in Cardiovascular Prevention Trials | Q57156318 | ||
| Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease | Q57197707 | ||
| Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial | Q57197723 | ||
| The role of early-life educational quality and literacy in explaining racial disparities in cognition in late life | Q35715730 | ||
| Comparison of reporting of ethnicity in US and European randomised controlled trials | Q35770787 | ||
| Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled | Q35869663 | ||
| Why ethnic minority groups are under-represented in clinical trials: a review of the literature | Q35890426 | ||
| Ethnic disparities in stroke: epidemiology, acute care, and postacute outcomes. | Q36002060 | ||
| Minority participation in randomized controlled trials for obsessive-compulsive disorder | Q36200991 | ||
| AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks | Q36380205 | ||
| Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial | Q36469959 | ||
| The search for migraine genes: an overview of current knowledge. | Q36691539 | ||
| Provider roles in the recruitment of underrepresented populations to cancer clinical trials | Q36698291 | ||
| Migraine care among different ethnicities: do disparities exist? | Q36743932 | ||
| Systematic review identified suboptimal reporting and use of race/ethnicity in general medical journals | Q36817446 | ||
| Gender and ethnic diversity in NIMH-funded clinical trials: review of a decade of published research. | Q36906743 | ||
| Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review | Q37002937 | ||
| Racial differences in hepatitis C treatment eligibility | Q37077462 | ||
| Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials | Q37382014 | ||
| Migraine prevalence, socioeconomic status, and social causation | Q37463575 | ||
| Disparities in deep brain stimulation surgery among insured elders with Parkinson disease | Q37499393 | ||
| Racial diversity in uterine leiomyoma clinical studies | Q37647167 | ||
| Minority inclusion in randomized clinical trials of panic disorder | Q37996709 | ||
| Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis | Q38006095 | ||
| The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies | Q38087404 | ||
| Pearls and pitfalls in genetic studies of migraine | Q38106687 | ||
| Reporting and representation of ethnic minorities in cardiovascular trials: a systematic review | Q38118421 | ||
| Migraine genetics: Part II. | Q38126970 | ||
| Lack of diversity in orthopaedic trials conducted in the United States | Q38201653 | ||
| The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey studies | Q38341554 | ||
| Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. | Q38565859 | ||
| Sumatriptan/naproxen sodium for the acute treatment of probable migraine without aura: a randomized study | Q39219303 | ||
| Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study | Q39250004 | ||
| Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study | Q39255809 | ||
| Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis | Q39256375 | ||
| MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine | Q39268172 | ||
| Reporting and representation of race/ethnicity in published randomized trials | Q39935914 | ||
| P433 | issue | 3 | |
| P921 | main subject | migraine | Q133823 |
| P304 | page(s) | 525-533 | |
| P577 | publication date | 2017-01-27 | |
| P1433 | published in | Headache | Q5689497 |
| P1476 | title | Minority Representation in Migraine Treatment Trials | |
| P478 | volume | 57 |
| Q91583584 | Alleviation of migraine symptoms by application of repetitive peripheral magnetic stimulation to myofascial trigger points of neck and shoulder muscles - A randomized trial |
| Q38709363 | Do racial/ethnic disparities exist in recommended migraine treatments in US ambulatory care? |
| Q91578049 | Quantifying Sex Bias in Clinical Studies at Scale With Automated Data Extraction |
Search more.